Cellectar biosciences stock price
Cellectar Biosciences Inc (CLRBZ) Stock Quote and detailed dividend history including dividend dates, yield, company news, and key financial metrics. Cellectar Biosciences (Nasdaq: CLRB) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and In depth view into CLRB (Cellectar Biosciences) stock including the latest price, news, dividend history, earnings information and financials. Company Name: Cellectar Biosciences Inc., Stock Symbol: CLRB, Industry: Biotechs, Total Posts: 7967, Last Post: 3/16/2020 10:26:59 PM. 30 Mar 2020 Cellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., is a clinical stage biopharmaceutical company. The Company is engaged in
Mar 16, 2020 · Real time Cellectar Biosciences, Inc. (CLRB) stock price quote, stock graph, news & analysis.
Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro metastatic disease; CLR 124 which could detects tumors and metastases in a broad range of cancers; and CLR 1502, a cancer CLRB | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for CELLECTAR BIOSCIENCES INC (CLRB), including profile, stock chart, recent news and events, analyst opinions, and research reports. CLRB Stock Price & Charts | Cellectar Biosciences In depth view into CLRB (Cellectar Biosciences) stock including the latest price, news, dividend history, earnings information and financials.
Cellectar Biosciences Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CLRB stock price. DOW JONES, A NEWS CORP COMPANY.
Cellectar BioSciences (CLRB) Stock Price History | wallmine Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro metastatic disease; CLR 124 which could detects tumors and metastases in a broad range of cancers; and CLR 1502, a cancer CLRB | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for CELLECTAR BIOSCIENCES INC (CLRB), including profile, stock chart, recent news and events, analyst opinions, and research reports. CLRB Stock Price & Charts | Cellectar Biosciences In depth view into CLRB (Cellectar Biosciences) stock including the latest price, news, dividend history, earnings information and financials.
Sep 06, 2019 · 3 Wall Street analysts have issued ratings and price targets for Cellectar Biosciences in the last 12 months. Their average twelve-month price target is $6.33, suggesting that the stock has a possible upside of 396.58%. The high price target for CLRB is $10.00 and the low price …
CLRB Price Target and Analyst Ratings (Cellectar Biosciences) Sep 06, 2019 · 3 Wall Street analysts have issued ratings and price targets for Cellectar Biosciences in the last 12 months. Their average twelve-month price target is $6.33, suggesting that the stock has a possible upside of 396.58%. The high price target for CLRB is $10.00 and the low price … CLRB Stock Price and Chart — NASDAQ:CLRB — TradingView View live CELLECTAR BIOSCIENCES INC chart to track its stock's price action. Find market predictions, CLRB financials and market news.
Cellectar Biosciences stock surges 23% premarket MarketWatch. Tuesday, July 17, 2018. 01:26 PM ET. Cellectar Biosciences shares surge 15% on results of one cancer patient in mid-stage trial MarketWatch. Wednesday, June 15, 2016. 09:16 AM ET. Cellectar's stock soars after positive results of a study of its tumor treatment MarketWatch. More
Real time CELLECTAR BIOSCIENCES, INC. (CLRBD) stock price quote, stock graph, news & analysis. CLRB Stock Quote - Cellectar BioSciences, Inc. Stock Price ...
Real-time trade and investing ideas on Cellectar Biosciences, Inc. CLRB from the largest community of traders and investors. Market Data by Xignite and BATS BZX Real-Time Price. LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in … CLRB Stock | CELLECTAR BIOSCIENCES Stock Price Today ...